These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26718276)

  • 1. G protein-coupled receptors: Illuminating orphan GPCRs.
    Crunkhorn S
    Nat Rev Drug Discov; 2016 Jan; 15(1):15. PubMed ID: 26718276
    [No Abstract]   [Full Text] [Related]  

  • 2. Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65.
    Huang XP; Karpiak J; Kroeze WK; Zhu H; Chen X; Moy SS; Saddoris KA; Nikolova VD; Farrell MS; Wang S; Mangano TJ; Deshpande DA; Jiang A; Penn RB; Jin J; Koller BH; Kenakin T; Shoichet BK; Roth BL
    Nature; 2015 Nov; 527(7579):477-83. PubMed ID: 26550826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68).
    Yu X; Huang XP; Kenakin TP; Slocum ST; Chen X; Martini ML; Liu J; Jin J
    J Med Chem; 2019 Aug; 62(16):7557-7574. PubMed ID: 31298539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-Dependent Enhancement of Ovarian Cancer G Protein-Coupled Receptor 1 Activation by Ogerin.
    Murakami S; Mochimaru Y; Musha S; Kojima R; Deai M; Mogi C; Sato K; Okajima F; Tomura H
    Zoolog Sci; 2020 Apr; 37(2):103-108. PubMed ID: 32282140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation.
    Ralbovsky JL; Lisko JG; Palmer JM; Mabus J; Chevalier KM; Schulz MJ; Dyatkin AB; Miskowski TA; Coats SJ; Hornby P; He W
    Bioorg Med Chem Lett; 2009 May; 19(10):2661-3. PubMed ID: 19375913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Basis of Ligand Dissociation from G Protein-Coupled Receptors and Predicting Residence Time.
    Guo D; IJzerman AP
    Methods Mol Biol; 2018; 1705():197-206. PubMed ID: 29188564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synoptic pharmacology: Detecting and assessing the pharmacological significance of ligands for orphan receptors.
    Kenakin TP
    Pharmacol Res; 2016 Dec; 114():284-290. PubMed ID: 26804250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present and future approaches to screening of G-protein-coupled receptors.
    Lundstrom K
    Future Med Chem; 2013 Apr; 5(5):523-38. PubMed ID: 23573971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DREADDs: novel tools for drug discovery and development.
    Lee HM; Giguere PM; Roth BL
    Drug Discov Today; 2014 Apr; 19(4):469-73. PubMed ID: 24184433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenopus oocyte electrophysiology in GPCR drug discovery.
    Hansen KB; Bräuner-Osborne H
    Methods Mol Biol; 2009; 552():343-57. PubMed ID: 19513662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptors in drug discovery.
    Nambi P; Aiyar N
    Assay Drug Dev Technol; 2003 Apr; 1(2):305-10. PubMed ID: 15090195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromaticity in cyanuric acid.
    Pérez-Manríquez L; Cabrera A; Sansores LE; Salcedo R
    J Mol Model; 2011 Jun; 17(6):1311-5. PubMed ID: 20820829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cAMP assays in GPCR drug discovery.
    Vasudevan NT
    Methods Cell Biol; 2017; 142():51-57. PubMed ID: 28964339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligands.
    Kamińska K; Ziemba J; Ner J; Schwed JS; Łażewska D; Więcek M; Karcz T; Olejarz A; Latacz G; Kuder K; Kottke T; Zygmunt M; Sapa J; Karolak-Wojciechowska J; Stark H; Kieć-Kononowicz K
    Eur J Med Chem; 2015 Oct; 103():238-51. PubMed ID: 26360048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [GPCRs heterodimerization: a new way towards the discovery of function for the orphan receptors?].
    Levoye A; Jockers R
    Med Sci (Paris); 2007; 23(8-9):746-50. PubMed ID: 17875294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Approaches to GPCR Ligand Screening for Drug Discovery.
    Kumari P; Ghosh E; Shukla AK
    Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Ligands Illuminate GPCR Molecular Pharmacology.
    Wacker D; Stevens RC; Roth BL
    Cell; 2017 Jul; 170(3):414-427. PubMed ID: 28753422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl-1,3,5-triazine derivatives as histamine H4 receptor ligands.
    Łażewska D; Więcek M; Ner J; Kamińska K; Kottke T; Schwed JS; Zygmunt M; Karcz T; Olejarz A; Kuder K; Latacz G; Grosicki M; Sapa J; Karolak-Wojciechowska J; Stark H; Kieć-Kononowicz K
    Eur J Med Chem; 2014 Aug; 83():534-46. PubMed ID: 24996140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New bitter blocker discovered, study finds.
    J Am Dent Assoc; 2011 Aug; 142(8):901. PubMed ID: 21919220
    [No Abstract]   [Full Text] [Related]  

  • 20. Orphan G protein-coupled receptors: The role in CNS disorders.
    Alavi MS; Shamsizadeh A; Azhdari-Zarmehri H; Roohbakhsh A
    Biomed Pharmacother; 2018 Feb; 98():222-232. PubMed ID: 29268243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.